PublisherDOIYearVolumeIssuePageTitleAuthor(s)Link
Clinical and Molecular Hepatology10.3350/cmh.2021.00722021272281-282Another oral antiviral treatment, but still far away from hepatitis B virus cureTai-Chung Tsenghttp://e-cmh.org/upload/pdf/cmh-2021-0072.pdf, http://e-cmh.org/journal/view.php?doi=10.3350/cmh.2021.0072, http://e-cmh.org/upload/pdf/cmh-2021-0072.pdf
Liver International10.1111/liv.136732018387-13Treatment of hepatitis C virus infection with direct-acting antiviral agents: 100% cure?Tarik Asselah, Patrick Marcellin, Raymond F. Schinazihttps://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1111%2Fliv.13673, http://onlinelibrary.wiley.com/wol1/doi/10.1111/liv.13673/fullpdf
Antiviral Research10.1016/0166-3542(94)90118-x19942317-18Oral session IV: Respiratory and hepatitis virus infectionshttps://api.elsevier.com/content/article/PII:016635429490118X?httpAccept=text/xml, https://api.elsevier.com/content/article/PII:016635429490118X?httpAccept=text/plain
Antiviral Research10.1016/0166-3542(95)00923-x199629177-82Summary: antiviral treatment of hepatitis C virusG.M. Dusheikohttps://api.elsevier.com/content/article/PII:016635429500923X?httpAccept=text/xml, https://api.elsevier.com/content/article/PII:016635429500923X?httpAccept=text/plain
Hepatitis C - From Infection to Cure10.5772/intechopen.759162018Hepatitis C Virus and InflammationBinod Kumar, Akshaya Ramachandran, Gulam Warishttp://www.intechopen.com/download/pdf/60872
Antiviral Research10.1016/j.antiviral.2015.07.0062015121152-159Treatment of chronic hepatitis B with pattern recognition receptor agonists: Current status and potential for a cureJinhong Chang, Ju-Tao Guohttps://api.elsevier.com/content/article/PII:S0166354215001692?httpAccept=text/xml, https://api.elsevier.com/content/article/PII:S0166354215001692?httpAccept=text/plain
Hepatitis C Virus10.1017/cbo9780511545320.0192002135-140Antiviral gene therapyhttps://www.cambridge.org/core/services/aop-cambridge-core/content/view/CCED17DDFA27DD658508D2C06D5F8544
Journal of Viral Hepatitis10.1111/jvh.181_12923201825137-138P2-060: Hepatitis C virus reinfection after successful treatment with all-oral, direct-acting antiviral therapy in a large population-based cohort including people who inject drugshttps://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1111%2Fjvh.181_12923, http://onlinelibrary.wiley.com/wol1/doi/10.1111/jvh.181_12923/fullpdf
Antiviral Research10.1016/0166-3542(93)90602-f199320163224 Treatment of chronic woodchuck hepatitis virus infection with thymosin alpha-1 (TA1)https://api.elsevier.com/content/article/PII:016635429390602F?httpAccept=text/xml, https://api.elsevier.com/content/article/PII:016635429390602F?httpAccept=text/plain
Current Treatment Options in Infectious Diseases10.1007/s40506-020-00231-82020123296-309Hepatitis C Virus in the Elderly in the Direct-Acting Antiviral Era: from Diagnosis to CureMubeen Khan Mohammed Abdul, Heather S. Snyder, Mythili Chunduru, Susan M.K. Lee, Sanjaya K. Satapathyhttps://link.springer.com/content/pdf/10.1007/s40506-020-00231-8.pdf, https://link.springer.com/article/10.1007/s40506-020-00231-8/fulltext.html, https://link.springer.com/content/pdf/10.1007/s40506-020-00231-8.pdf